Canadians are sick and tired of feeling sick and tired. Despite scientific advancements and pharmaceutical promises, chronic and neuropathic pain remains a daily challenge for healthcare practitioners and patients. With one in five Canadians suffering from chronic pain, millions of Canadians are seeking ways to improve their quality of life and manage their symptoms—and ZYUS believes that plant-made therapeutics may offer a solution.
Saskatoon-based life sciences company ZYUS is working to advance the science of well-being and shift the paradigm from conventional strategies by reimagining the potential of plant-made therapeutics, including innovative cannabinoid-based formulations.
We speak further with ZYUS CEO Brent Zettl about his passion for helping patients, his plans for expansion and why he believes that a greater understanding of cannabinoids can have a huge impact on patient outcomes.
Read the full article on Macleans.ca